'The Revolving Door of Cancer Drug Development: Bench to Bed and Back to the Bench'

In this section
'The Revolving Door of Cancer Drug Development: Bench to Bed and Back to the Bench'
-

This is a past event

William Douglas Figg, Sr., Head of Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, NIH

Cell Developmental and Cancer Biology Seminar Programme